RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

Regulatory Focus™ > News Articles > RA Manager: The Virtual Regulatory Affairs Department

RA Manager: The Virtual Regulatory Affairs Department

Posted 01 February 2008 | By

The pharmaceutical, biologics and medical device industries are made up of companies that range from the very small-one executive with a promising technology, a check book, and a Rolodex-to companies with more than 50,000 employees and full manufacturing capabilities. Some small companies are run as "virtual" companies; that is, there are no internal research and development or manufacturing capabilities and very limited operational support. In some cases, these companies look externally for intellectual property (IP) to develop and then out-license, sell or use to attract funding to build a larger company.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.